Indeed CLL cells can release a subset of EV carrying CD52 but only few CD19 molecules; this particular marker combination was shown to be characteristic of CLL patients with advanced disease (38). This evidence concerns the gene CD52 and B-cell chronic lymphocytic leukemia.